scholarly article | Q13442814 |
P356 | DOI | 10.1093/EMBOJ/20.9.2273 |
P8608 | Fatcat ID | release_tul6sagzhvc6lab64pawdxts74 |
P932 | PMC publication ID | 125435 |
P698 | PubMed publication ID | 11331592 |
P5875 | ResearchGate publication ID | 232776088 |
P2093 | author name string | C M Yang | |
D M Hentschel | |||
E O'Leary | |||
J V Bonventre | |||
K G Sim | |||
S I Hsu | |||
P2860 | cites work | Structure and ligand of a histone acetyltransferase bromodomain | Q22009928 |
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas | Q24294176 | ||
Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1 | Q24317298 | ||
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation | Q24318303 | ||
Identification and characterization of a leukocyte-specific component of the nuclear body | Q24319438 | ||
Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression | Q24522749 | ||
Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system | Q24596103 | ||
Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1) | Q24597148 | ||
A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins | Q24654804 | ||
Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1 | Q28275216 | ||
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product | Q28284880 | ||
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor | Q28286827 | ||
A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors | Q28504688 | ||
The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18 | Q28509358 | ||
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase | Q28612948 | ||
Modular binding domains in signal transduction proteins | Q29617351 | ||
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties | Q29620009 | ||
Does this have a familiar RING? | Q29620258 | ||
The PHD finger: implications for chromatin-mediated transcriptional regulation | Q29620426 | ||
Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product | Q29620442 | ||
Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia | Q33268330 | ||
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein | Q34313966 | ||
The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. | Q35238471 | ||
Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1 | Q36560847 | ||
RB and hbrm cooperate to repress the activation functions of E2F1 | Q36591354 | ||
An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription | Q36765388 | ||
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. | Q37469268 | ||
A new component of the transcription factor DRTF1/E2F. | Q38321048 | ||
A physical map of 30,000 human genes | Q38476708 | ||
The CBP co-activator stimulates E2F1/DP1 activity | Q39718005 | ||
DP and E2F proteins: coordinating transcription with cell cycle progression. | Q40606660 | ||
A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. | Q40656289 | ||
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein | Q40656395 | ||
Identification of a growth suppression domain within the retinoblastoma gene product | Q41619792 | ||
The bromodomain revisited. | Q48050242 | ||
The bromodomain of Gcn5p interacts in vitro with specific residues in the N terminus of histone H4 | Q56902298 | ||
An improved procedure for the purification of protein fused with glutathione S-transferase | Q67979721 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | E2F transcription factor 1 | Q15333021 |
Transcription factor Dp 1 | Q21495535 | ||
Nuclear transcription factor, X-box binding 1 | Q21496625 | ||
Tripartite motif-containing 24 | Q21498067 | ||
Cyclin A2 | Q21499230 | ||
E1A binding protein p300 | Q21981065 | ||
RB transcriptional corepressor 1 | Q21982891 | ||
Tripartite motif-containing 28 | Q21990392 | ||
SERTA domain containing 2 | Q21991737 | ||
SERTA domain containing 1 | Q21991738 | ||
P304 | page(s) | 2273-2285 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1 | |
P478 | volume | 20 |
Q40251174 | ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD-histone contacts. |
Q36594956 | Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance |
Q78476989 | Abundance of the RSC nucleosome-remodeling complex is important for the cells to tolerate DNA damage in Saccharomyces cerevisiae |
Q50335520 | Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). |
Q45223326 | Analysis of gene expression changes in a cellular model of Parkinson disease |
Q34508316 | BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas |
Q40229927 | CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation |
Q47276356 | CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF‑7/ADM human breast cancer cell line |
Q40006400 | CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein |
Q53596494 | Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. |
Q39689428 | Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers |
Q41936208 | Clinical and molecular characterization of two patients with overlapping de novo microdeletions in 2p14-p15 and mild mental retardation |
Q36887697 | Control of sleep by a network of cell cycle genes. |
Q34280071 | Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors |
Q91677970 | DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies |
Q58919335 | Derailing the UPS of Protein Turnover in Cancer and other Human Diseases |
Q38999295 | Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells. |
Q92598248 | Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation |
Q52681173 | E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. |
Q24646412 | E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases |
Q64059350 | Engraftment and proliferation potential of embryonic lung tissue cells in irradiated mice with emphysema |
Q28506833 | Evolutionary conservation and murine embryonic expression of the gene encoding the SERTA domain-containing protein CDCA4 (HEPP) |
Q100994562 | Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis |
Q35846780 | FH535 inhibited metastasis and growth of pancreatic cancer cells |
Q44702500 | I-mfa domain proteins specifically interact with SERTA domain proteins and repress their transactivating functions |
Q38302657 | Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation |
Q89683476 | Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum Starvation |
Q38781625 | Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines. |
Q34353406 | Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells |
Q36416146 | Investigating the genetic circuitry of mastermind in Drosophila, a notch signal effector |
Q36148385 | KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation |
Q35409103 | KIM-1-mediated phagocytosis reduces acute injury to the kidney |
Q28975623 | Kelch Repeat and BTB Domain Containing Protein 5 (Kbtbd5) Regulates Skeletal Muscle Myogenesis through the E2F1-DP1 Complex |
Q64102524 | Knockdown of cell division cycle-associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA-MB-231 cells and |
Q93060362 | Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c |
Q38699455 | NMR uncovers direct interaction between human NEDD4-1 and p34SEI-1. |
Q33525540 | Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1. |
Q35781341 | Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAP. |
Q45327505 | Oncogenic function of p34SEI-1 via NEDD4‑1‑mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway |
Q40390499 | Oncogenic transformation by SEI-1 is associated with chromosomal instability |
Q40177755 | Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth |
Q34186659 | PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein |
Q33347938 | Phosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1. |
Q64113582 | Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis |
Q35147982 | Regulation of CDK4 |
Q37880852 | Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer |
Q38024616 | Role of host cell factor-1 in cell cycle regulation. |
Q24314613 | SEI family of nuclear factors regulates p53-dependent transcriptional activation |
Q38742708 | SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer |
Q91867795 | SERTA Domain Containing Protein 1 (SERTAD1) Interacts with Classical Swine Fever Virus Structural Glycoprotein E2, Which Is Involved in Virus Virulence in Swine |
Q41586533 | SIAH1-induced p34SEI-1 polyubiquitination/degradation mediates p53 preferential vitamin C cytotoxicity. |
Q47106228 | Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells |
Q28594857 | Sertad1 encodes a novel transcriptional co-activator of SMAD1 in mouse embryonic hearts |
Q40242419 | Sertad1 plays an essential role in developmental and pathological neuron death. |
Q59352362 | Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain |
Q28507542 | Strain-specific complementation between NRIF1 and NRIF2, two zinc finger proteins sharing structural and biochemical properties |
Q64283179 | Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells |
Q40171341 | Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain |
Q36025953 | TARANIS Functions with Cyclin A and Cdk1 in a Novel Arousal Center to Control Sleep in Drosophila. |
Q53282568 | TIF1β association with HP1 is essential for post-gastrulation development, but not for Sertoli cell functions during spermatogenesis. |
Q37164834 | TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors |
Q50581530 | Taranis Protects Regenerating Tissue from Fate Changes Induced by the Wound Response in Drosophila. |
Q37520306 | The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain |
Q28512185 | The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification |
Q46386523 | The Drosophila SERTAD protein Taranis determines lineage-specific neural progenitor proliferation patterns |
Q34614275 | The Drosophila gene taranis encodes a novel trithorax group member potentially linked to the cell cycle regulatory apparatus |
Q44238506 | The Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein |
Q40970772 | The complex of TRIP-Br1 and XIAP ubiquitinates and degrades multiple adenylyl cyclase isoforms |
Q33292454 | The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. |
Q40201734 | Transcriptional and subcellular regulation of the TRIP-Br family |
Q46524984 | Transcriptional co-factor CDCA4 participates in the regulation of JUN oncogene expression |
Q28646920 | Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions |
Q36755479 | YB-1, the E2F pathway, and regulation of tumor cell growth |
Q34378916 | p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN. |
Q54710302 | p34SEI-1 inhibits doxorubicin-induced senescence through a pathway mediated by protein kinase C-delta and c-Jun-NH2-kinase 1 activation in human breast cancer MCF7 cells. |